Prognostic value of body composition on early recurrence and long-term survival of resectable pancreatic ductal adenocarcinoma - Takeaways - MDSpire

Prognostic value of body composition on early recurrence and long-term survival of resectable pancreatic ductal adenocarcinoma

  • By

  • Linxia Wu

  • Tong Nie

  • Xiaoling Zhi

  • Die Ouyang

  • Licai Zhang

  • Hongying Wu

  • Xin Li

  • Heshui Wu

  • Ping Han

  • Lei Chen

  • Feihong Wu

  • Chuansheng Zheng

  • November 10, 2025

  • 0 min

Share

  • 1

    Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with a 5-year survival rate below 20% and high rates of tumor recurrence.

  • 2

    Early recurrence (ER) occurs in up to 80% of PDAC patients within 5 years post-surgery, significantly worsening prognosis.

  • 3

    Body composition, particularly skeletal muscle quality and visceral fat accumulation, is linked to recurrence and survival in PDAC.

  • 4

    CT imaging is effective for assessing body composition parameters, which can aid in predicting ER and tailoring treatment strategies.

  • 5

    The study aims to evaluate CT-quantified body composition's prognostic value for ER and long-term survival in resectable PDAC patients.

Original Source(s)

Related Content